CD8A and neoplasm: Although the checkpoint inhibition hypothesis is compelling for modification of the tumor microenvironment, such agents cannot elicit polyclonal expansion of antitumoral CD8+ Teff and NK cells, nor do they consistently modulate trafficking of immune cells into tumor sites or enhance expression of tumor antigens to improve antitumor immune responses.